APA

Yoshimura R., Hori H., Sugita A., Ueda N., Kakihara S., Umene W., Nakano Y., Shinkai K., Mitoma M., Ohta M., Shinkai T. & Nakamura J. (20070828). Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. : Progress in neuro-psychopharmacology & biological psychiatry.

Chicago

Yoshimura Reiji, Hori Hikaru, Sugita Atsuko, Ueda Nobuhisa, Kakihara Shingo, Umene Wakako, Nakano Yuichiro, Shinkai Koji, Mitoma Masae, Ohta Makiko, Shinkai Takahiro and Nakamura Jun. 20070828. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. : Progress in neuro-psychopharmacology & biological psychiatry.

Harvard

Yoshimura R., Hori H., Sugita A., Ueda N., Kakihara S., Umene W., Nakano Y., Shinkai K., Mitoma M., Ohta M., Shinkai T. and Nakamura J. (20070828). Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. : Progress in neuro-psychopharmacology & biological psychiatry.

MLA

Yoshimura Reiji, Hori Hikaru, Sugita Atsuko, Ueda Nobuhisa, Kakihara Shingo, Umene Wakako, Nakano Yuichiro, Shinkai Koji, Mitoma Masae, Ohta Makiko, Shinkai Takahiro and Nakamura Jun. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. : Progress in neuro-psychopharmacology & biological psychiatry. 20070828.